Psygen Announces use of Psilocybin in Human Trial and Provides Update on IP Portfolio
- Written by Newsfile
- patent applications filed for manufacturing processes
- patent-pending technology aims to improve yields and ultimately margins
Calgary, Alberta--(Newsfile Corp. - October 6, 2021) - Psygen Industries Ltd. ("Psygen" or the "Company") provided an update today on use of psilocybin in humans and on its intellectual property portfolio. Psygen is excited...

